-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Gentex, Lowers Price Target to $21

Benzinga·10/26/2026 18:47:31
Listen to the news
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $24 to $21.